OB:ELABS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Elliptic Laboratories

Market Cap

kr2.3b

Last Updated

2021/07/31 16:22 UTC

Data Sources

Company Financials

Executive Summary

Elliptic Laboratories A/S provides software-based artificial intelligence (AI) virtual smart sensors in Norway, China, South Korea, the United States, and Japan. More Details


Snowflake Analysis

Excellent balance sheet with weak fundamentals.

Share Price & News

How has Elliptic Laboratories's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ELABS is more volatile than 75% of Norwegian stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: ELABS's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.


Market Performance


7 Day Return

-1.9%

ELABS

3.7%

NO Software

0.2%

NO Market


1 Year Return

n/a

ELABS

33.6%

NO Software

31.8%

NO Market

Return vs Industry: Insufficient data to determine how ELABS performed against the Norwegian Software industry.

Return vs Market: Insufficient data to determine how ELABS performed against the Norwegian Market.


Shareholder returns

ELABSIndustryMarket
7 Day-1.9%3.7%0.2%
30 Day37.1%5.9%0.2%
90 Day30.8%-6.5%2.0%
1 Yearn/a33.6%33.6%36.6%31.8%
3 Yearn/a48.0%40.6%18.2%4.8%
5 Yearn/a101.8%85.1%76.9%44.2%

Long-Term Price Volatility Vs. Market

How volatile is Elliptic Laboratories's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Elliptic Laboratories undervalued compared to its fair value and its price relative to the market?

12.65x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate ELABS's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate ELABS's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: ELABS is unprofitable, so we can't compare its PE Ratio to the European Software industry average.

PE vs Market: ELABS is unprofitable, so we can't compare its PE Ratio to the Norwegian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ELABS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ELABS is overvalued based on its PB Ratio (12.6x) compared to the NO Software industry average (3.6x).


Future Growth

How is Elliptic Laboratories forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

45.8%

Forecasted Software industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Elliptic Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Elliptic Laboratories performed over the past 5 years?

31.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ELABS is currently unprofitable.

Growing Profit Margin: ELABS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ELABS is unprofitable, but has reduced losses over the past 5 years at a rate of 31.4% per year.

Accelerating Growth: Unable to compare ELABS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ELABS is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (18.6%).


Return on Equity

High ROE: ELABS has a negative Return on Equity (-5.67%), as it is currently unprofitable.


Financial Health

How is Elliptic Laboratories's financial position?


Financial Position Analysis

Short Term Liabilities: ELABS's short term assets (NOK109.0M) exceed its short term liabilities (NOK13.4M).

Long Term Liabilities: ELABS's short term assets (NOK109.0M) exceed its long term liabilities (NOK15.5M).


Debt to Equity History and Analysis

Debt Level: ELABS's debt to equity ratio (9.4%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if ELABS's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ELABS has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: ELABS has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 24.3% each year


Dividend

What is Elliptic Laboratories's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ELABS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ELABS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ELABS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ELABS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ELABS's dividend in 3 years as they are not forecast to pay a notable one for the Norwegian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.3yrs

Average management tenure


CEO

Laila Danielsen

8yrs

Tenure

Ms. Laila B. Danielsen serves as Chief Executive Officer and President of Elliptic Laboratories AS. Ms. Danielsen served as Vice President of sales at HotLink Corporation. Ms. Danielsen served as Vice Pres...


Leadership Team

Experienced Management: ELABS's management team is seasoned and experienced (7.3 years average tenure).


Board Members

Experienced Board: ELABS's board of directors are considered experienced (7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: ELABS only recently listed within the past 12 months.


Top Shareholders

Company Information

Elliptic Laboratories AS's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Elliptic Laboratories AS
  • Ticker: ELABS
  • Exchange: OB
  • Founded: 2006
  • Industry: Application Software
  • Sector: Software
  • Market Cap: kr2.283b
  • Shares outstanding: 9.59m
  • Website: https://www.ellipticlabs.com

Number of Employees


Location

  • Elliptic Laboratories AS
  • Akersgata 32
  • Oslo
  • Oslo
  • 180
  • Norway

Listings


Biography

Elliptic Laboratories A/S provides software-based artificial intelligence (AI) virtual smart sensors in Norway, China, South Korea, the United States, and Japan. It offers AI virtual sensors, such as secur...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/31 16:22
End of Day Share Price2021/07/30 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.